Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$540M |
| 2 |
Citizens Financial Group
CFG
|
+$304M |
| 3 |
Analog Devices
ADI
|
+$303M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$293M |
| 5 |
Travelers Companies
TRV
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$548M |
| 2 |
Micron Technology
MU
|
+$461M |
| 3 |
Citigroup
C
|
+$334M |
| 4 |
Broadcom
AVGO
|
+$319M |
| 5 |
AbbVie
ABBV
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.23% |
| 2 | Financials | 5.58% |
| 3 | Industrials | 4.98% |
| 4 | Consumer Discretionary | 4.95% |
| 5 | Healthcare | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
4076
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.06M | ﹤0.01% |
67,332
-1,331,461
| -95% | -$19.5M |
|
|
IBDD
4077
DELISTED
iShares iBonds Mar 2023 Term Corporate ETF
IBDD
| $1.06M | ﹤0.01% |
39,771
-1,313
| -3% | -$35.1K |
|
4078
PUT
InterDigital
IDCC
$8.87B
| $1.06M | ﹤0.01% |
14,400
+6,200
| +76% | +$454K |
|
4079
Midland States Bancorp
MSBI
$693M
| $1.06M | ﹤0.01% |
33,526
+26,118
| +353% | +$825K |
|
4080
CALL
Vanguard Dividend Appreciation ETF
VIG
$114B
| $1.06M | ﹤0.01% |
11,200
+7,800
| +229% | +$728K |
|
4081
WEC Energy
WEC
$36B
| $1.06M | ﹤0.01% |
16,915
-80,126
| -83% | -$5.11M |
|
|
TVRD
4082
Tvardi Therapeutics
TVRD
$25.3M
| $1.06M | ﹤0.01% |
2,155
-363
| -14% | -$182K |
|
|
ARCH
4083
PUT
DELISTED
Arch Resources, Inc.
ARCH
| $1.06M | ﹤0.01% |
14,800
+6,000
| +68% | +$449K |
|
4084
Essex Property Trust
ESS
$18.5B
| $1.06M | ﹤0.01% |
4,177
-1,706
| -29% | -$446K |
|
4085
CALL
Voya Financial
VOYA
$9.2B
| $1.06M | ﹤0.01% |
26,600
-7,900
| -23% | -$303K |
|
|
GOOS
4086
PUT
Canada Goose Holdings
GOOS
$854M
| $1.06M | ﹤0.01% |
51,600
-58,600
| -53% | -$1.11M |
|
|
BPMC
4087
PUT
DELISTED
Blueprint Medicines
BPMC
| $1.06M | ﹤0.01% |
15,200
+1,300
| +9% | +$69.5K |
|
4088
St. Joe Company
JOE
$3.89B
| $1.06M | ﹤0.01% |
+56,110
| New | +$1.04M |
|
4089
Laureate Education
LAUR
$5.18B
| $1.06M | ﹤0.01% |
72,662
-446,374
| -86% | -$7M |
|
|
CHL
4090
PUT
DELISTED
China Mobile Limited
CHL
| $1.06M | ﹤0.01% |
20,900
-44,400
| -68% | -$2.37M |
|
4091
Genesis Energy
GEL
$1.93B
| $1.06M | ﹤0.01% |
+40,066
| New | +$1.14M |
|
4092
CALL
Herc Holdings
HRI
$5.8B
| $1.06M | ﹤0.01% |
21,500
+11,300
| +111% | +$490K |
|
|
HSII
4093
DELISTED
Heidrick & Struggles
HSII
| $1.05M | ﹤0.01% |
49,887
+40,485
| +431% | +$790K |
|
|
BKI
4094
DELISTED
Black Knight, Inc. Common Stock
BKI
| $1.05M | ﹤0.01% |
24,473
-121,394
| -83% | -$5.15M |
|
4095
PUT
Hewlett Packard
HPE
$77.7B
| $1.05M | ﹤0.01% |
71,600
-79,600
| -53% | -$1.09M |
|
4096
ProShares UltraShort Russell2000
TWM
$40.4M
| $1.05M | ﹤0.01% |
+2,815
| New | +$1.18M |
|
4097
ProShares Ultra Energy
DIG
$85.6M
| $1.05M | ﹤0.01% |
23,776
+5,422
| +30% | +$214K |
|
|
DCP
4098
DELISTED
DCP Midstream, LP
DCP
| $1.05M | ﹤0.01% |
30,343
+22,539
| +289% | +$742K |
|
4099
Citi Trends
CTRN
$616M
| $1.05M | ﹤0.01% |
52,847
+822
| +2% | +$16.3K |
|
4100
CALL
Jones Lang LaSalle
JLL
$17.3B
| $1.05M | ﹤0.01% |
8,500
+2,200
| +35% | +$272K |
|
Similar funds
Ken Griffin's Q3 2017 Portfolio in Review
As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
- Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
- Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
- Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
- Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
- Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.